CASP7 overexpression was found to significantly reduce the expression of cell cycle inhibitor, p21Cip in both the breast cancer cells (MCF7 ~2.5-fold; T47D ~1.6-fold) (Figure 8a). Here, CASP7 is linked to breast carcinoma.